Low Operational Costs
Salt-free fermentation in non-halophilic hosts eliminates equipment corrosion and high salt disposal costs, solving high salinity problems.
Ectoine is a powerful extremolyte widely used in cosmetics and skincare as a stress protectant, stabilizing proteins and cell membranes against dehydration, heat, and high salinity. Traditional industrial production relies on halophilic microorganisms (e.g., Halomonas elongata). This approach presents two major operational and economic constraints. Firstly, Traditional halophile fermentation requires high salinity (e.g., 2.5-5.5 M NaCl), which leads to equipment corrosion and high operational costs (high salt disposal). Secondly, the Ectoine product is mainly accumulated intracellularly as an osmoprotectant, requiring a complex and costly Osmotic Shock extraction process or cell lysis, increasing downstream expenses.
CD Biosynsis offers a comprehensive synthetic biology and metabolic engineering solution to overcome these limitations. To eliminate the high operational costs associated with salt, we implement Heterologous expression of the ectABC gene cluster into non-halophilic industrial hosts (e.g., E. coli, C. glutamicum). This allows Ectoine production in low-salt or salt-free media. To maximize the efficiency and titer, we apply metabolic engineering: We perform Knockout competitive pathways (e.g., Lysine, Pyruvate pathways) to redirect the carbon flux from the common precursor, Aspartate-4-semialdehyde, directly to the Ectoine synthesis genes (ectA, ectB, ectC). Finally, to ensure high activity of the Ectoine biosynthesis enzymes, we optimize the pathway through Transcriptional balancing and/or codon optimization of ectA, ectB, ectC to achieve optimal enzyme ratios and high titer. This integrated strategy provides a highly efficient, low-cost, and easily purifiable Ectoine production system.
Get a QuoteIndustrial Ectoine production faces these key challenges:
A successful solution must eliminate high salt requirements and simplify extraction.
CD Biosynsis utilizes advanced metabolic engineering and synthetic biology to optimize Ectoine production:
Heterologous Expression of ectABC Cluster into Non-Halophilic Hosts
We move the ectoine genes into robust industrial strains (E. coli, C. glutamicum) to enable low-salt fermentation , solving the high salinity issue.
Knockout Competitive Pathways to Maximize Carbon Flux to Ectoine
We use CRISPR to delete gene pathways competing for ASA (e.g., Lysine pathway genes), boosting Ectoine yield.
Transcriptional Balancing and Codon Optimization of ectABC
We use combinatorial promoter libraries to fine-tune ect gene expression and ensure optimal enzyme ratios for high titer.
Efflux Pump Engineering for Extracellular Accumulation
We overexpress native or heterologous efflux pumps to export Ectoine out of the cell, simplifying extraction and purification, addressing intracellular accumulation.
This systematic approach provides a high-yield, low-cost, and environmentally friendly route for Ectoine production.
Our Ectoine engineering service is dedicated to pursuing the following production goals:
Low Operational Costs
Salt-free fermentation in non-halophilic hosts eliminates equipment corrosion and high salt disposal costs, solving high salinity problems.
Simplified Downstream Processing
Efflux pump engineering enables extracellular accumulation, avoiding Osmotic Shock extraction and complex purification.
High Ectoine Titer and Yield Icon
Knockout of competitive pathways ensures maximal carbon flux to Ectoine, resulting in superior yield. [Image of Cost Reduction Icon]
Sustainable Production Icon
Using robust industrial hosts and low-salt media aligns with green chemistry principles.
Robust Fermentation Icon
Industrial hosts (E. coli, C. glutamicum) are optimized for high-density fermentation performance.
We provide a cost-effective, high-yield, and scalable biosynthetic route for Ectoine.
Our Ectoine strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product localization.
Explore the potential for a cost-effective, high-yield Ectoine supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is high salinity needed in traditional halophile fermentation ?
In native halophilic bacteria, Ectoine is produced as an osmoprotectant . It only accumulates at high concentrations when the external salt concentration (NaCl) is high, signaling the cell needs to counteract the osmotic stress. This natural requirement is the source of the high operational costs .
How does Heterologous Expression in non-halophiles solve the problem?
When the ectABC genes are expressed in a non-halophile host (E. coli), the Ectoine is produced constitutively (constantly) or via an inducible promoter rather than being dependent on salt stress. This allows high yield in low-salt or salt-free media , eliminating the corrosion and disposal issues.
Why is Osmotic Shock Extraction complex and costly?
It involves repeatedly cycling the cells between high and low salt concentrations to induce the transient release of Ectoine from the cells. This process is time-consuming, requires precise control, and often leads to the release of other cellular components , complicating the final purification step.
What is the benefit of Knockout Competitive Pathways ?
By deleting genes that convert the common precursor ASA into other amino acids (e.g., Lysine), we create a metabolic funnel that forces all available carbon flux into the Ectoine pathway, achieving the highest possible theoretical yield .
What is the estimated project timeline?
A project involving multi-gene pathway integration, multiple gene knockouts, and efflux pump engineering typically requires 24-32 weeks for final industrial strain delivery and performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.